| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Lin JH | |
| P433 | issue | 12 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 1202-1212 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Drug Metabolism and Disposition | Q1261140 |
| P1476 | title | Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics | |
| P478 | volume | 26 |
| Q30486621 | (+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats |
| Q37244754 | (+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks. |
| Q34565712 | 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings |
| Q39744489 | A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. |
| Q83204523 | A novel strategy for physiologically based predictions of human pharmacokinetics |
| Q35647136 | A semiphysiologically based pharmacokinetic modeling approach to predict the dose-exposure relationship of an antiparasitic prodrug/active metabolite pair. |
| Q33941234 | Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse. |
| Q90701824 | Antiretroviral Penetration across Three Preclinical Animal Models and Humans in Eight Putative HIV Viral Reservoirs |
| Q36925745 | Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition |
| Q47860080 | Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics. |
| Q43663687 | Development of a physiologically based model for oseltamivir and simulation of pharmacokinetics in neonates and infants |
| Q37689854 | Development of a physiologically-based pharmacokinetic model of the rat central nervous system. |
| Q33887039 | Difference in desipramine metabolic profile between wild-type and CYP2D6-humanized mice |
| Q21144682 | Erythrocyte G protein as a novel target for malarial chemotherapy |
| Q93187907 | Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset |
| Q40256176 | HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities |
| Q37948908 | Humanized transgenic mouse models for drug metabolism and pharmacokinetic research |
| Q83887396 | In vitro characterization of rosiglitazone metabolites and determination of the kinetic parameters employing rat liver microsomal fraction |
| Q37116223 | In vitro screening for the tumoricidal properties of international medicinal herbs |
| Q34213547 | In vitro screening of tumoricidal properties of international medicinal herbs: part II. |
| Q26996411 | Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects? |
| Q92934655 | Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling |
| Q34299078 | Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing |
| Q97074175 | Measuring the Stability of Supramolecular Complexes in the Proximity of Single-Walled Carbon Nanotubes |
| Q47135280 | Nam Dia long, a Vietnamese folk formula, induces apoptosis in MCF-7 cells through various mechanisms of action |
| Q24619949 | Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA) |
| Q40717603 | Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain |
| Q35188408 | Pharmacokinetic-pharmacodynamic guided trial design in oncology |
| Q37554225 | Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab. |
| Q48178968 | Preclinical pharmacokinetics and interspecies scaling of ragaglitazar, a novel biliary excreted PPAR dual activator |
| Q37196026 | Quantitation of human cytochrome P450 2D6 protein with immunoblot and mass spectrometry analysis |
| Q37358441 | Radiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results. |
| Q37831422 | Shiga toxin and its use in targeted cancer therapy and imaging |
| Q33571451 | Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling |
| Q35049310 | Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies. |
| Q35393618 | Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice |
| Q28751735 | To scale or not to scale: the principles of dose extrapolation |
| Q36666580 | Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges |
| Q89982792 | Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids |
Search more.